InVivoMAb anti-WNV E protein DIII-LR

Type I IFN stimulates lymph node stromal cells from adult and old mice during a West Nile virus infection.

Plant-Produced Antigen Displaying Virus-Like Particles Evokes Potent Antibody Responses against West Nile Virus in Mice.

A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions.

A novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice.

A novel approach for the rapid mutagenesis and directed evolution of the structural genes of west nile virus.

The interferon-inducible gene viperin restricts West Nile virus pathogenesis.

A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus. Dowd KA et al., 2011 Jun, PLoS Pathog

A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.

A therapeutic antibody against west nile virus neutralizes infection by blocking fusion within endosomes.

Toll-like receptor 3 has a protective role against West Nile virus infection.